Ultragenyx Pharmaceutical Inc. (0LIF.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 05:15PM BST
| Previous close | 41.32 |
| Open | 40.97 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 40.41 - 41.00 |
| 52-week range | 31.83 - 54.48 |
| Volume | |
| Avg. volume | 302 |
| Market cap | 23.537M |
| Beta (5Y monthly) | 0.68 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2024 Earnings Call Transcript
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q1 2024 Earnings Call Transcript May 2, 2024 Ultragenyx Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $-2.02505 EPS, expectations were $-1.72. RARE isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome […]
- Simply Wall St.
Here's What Analysts Are Forecasting For Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) After Its First-Quarter Results
Ultragenyx Pharmaceutical Inc. ( NASDAQ:RARE ) just released its latest first-quarter report and things are not looking...
- GuruFocus.com
Ultragenyx Pharmaceutical Inc (RARE) (Q1 2024) Earnings Call Transcript Highlights: Key ...
Explore Ultragenyx Pharmaceutical's Q1 2024 financial performance, strategic milestones, and expert insights from the latest earnings call.
© 2024 Yahoo. All rights reserved.